Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Am Heart J. 2011 Nov 17;163(1):119–124.e1. doi: 10.1016/j.ahj.2011.09.029

Table II.

Cox proportional hazards models relating loge resistin and adiponectin to incident AF

Adjustment
factors		 Loge resistin Loge adiponectin
HR* P HR* P
No adjustment 1.33 (1.17–1.52) <.001 0.95 (0.83–1.09) .439
Age and sex 1.19 (1.04–1.37)   .011 0.91 (0.78–1.06) .205
Age, sex, BMI 1.15 (1.00–1.32)   .050 0.97 (0.83–1.14) .719
AF risk score 1.17 (1.02–1.34)   .028 0.95 (0.81–1.10) .478
AF risk score and CRP 1.14 (0.99–1.31)   .073 0.95 (0.82–1.11) .547
AF risk score and interim heart failure 1.16 (1.01–1.33)   .034 0.95 (0.81–1.11) .486

AF, Atrial fibrillation; BMI, body mass index.

AF risk score (age, sex, body mass index, systolic blood pressure, treatment of hypertension, PR interval, clinically significant cardiac murmur, and heart failure).26

*

Hazard ratios are relative to 1 SD (0.41 ng/mL for resistin and 0.62 µg/mL for adiponectin) increase in loge resistin or adiponectin, respectively, and 95% CI.